BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4229278)

  • 1. [Development of the genital structures from puberty to adult age in male pseudohermaphrodites obtained by injection of estrogens in pregnant mice].
    Jean C
    C R Seances Soc Biol Fil; 1967 Nov; 161(5):1057-62. PubMed ID: 4229278
    [No Abstract]   [Full Text] [Related]  

  • 2. [Genital malformations induced in adult mice by a prenatal estrogenic action. I. The male (male pseudo-hermaphroditism)].
    Jean C
    Arch Anat Microsc Morphol Exp; 1968; 57(2):121-66. PubMed ID: 4387385
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sexual malformation of the adult female mouse caused by injection of estrogens to the pregnant mother].
    Jean C
    C R Seances Soc Biol Fil; 1966; 160(5):976-81. PubMed ID: 4225111
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of effect of spironolactone on male genital development.
    Rose LI; Regestein Q; Reckler JM
    Invest Urol; 1975 Sep; 13(2):95-6. PubMed ID: 1184344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diethylstilbestrol. Tragic late effect after prenatal exposure].
    Forsberg JG
    Lakartidningen; 1993 Apr; 90(15):1470, 1473-6. PubMed ID: 8479275
    [No Abstract]   [Full Text] [Related]  

  • 6. [Stimulation by postnatal estrogen treatment of female genital structures obtained in male adult mice by injection of estradiol in the pregnant mother].
    Jean C; Delost P
    J Physiol (Paris); 1967; 59(1 Suppl):246-7. PubMed ID: 4389015
    [No Abstract]   [Full Text] [Related]  

  • 7. [Genital development of the offsprings of animals treated with reserpine during pregnancy].
    Giordano G
    Riv Ostet Ginecol; 1967 Oct; 22(10):761-71. PubMed ID: 5618773
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anabolic steroids and pathology of the sexual development].
    Cruz M; Frances JM
    Minerva Med; 1971 Jun; 62(51):2580-4. PubMed ID: 5566871
    [No Abstract]   [Full Text] [Related]  

  • 9. [The fetal risk in endocrine treatments].
    Laplane R; Georges-Janet L
    Presse Med (1893); 1968 Apr; 76(17):785-7. PubMed ID: 4171401
    [No Abstract]   [Full Text] [Related]  

  • 10. Ambiguous genitalia: an overview of 22 years experience and the diagnostic approach in the Pediatric Department, Siriraj Hospital.
    Nimkarn S; Likitmaskul S; Sangacharoenkit P; Pathomvanich A; Sawathiparnich P; Wacharasindhu S; Punnakanta L; Angsusingha K; Tuchinda C
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S496-505. PubMed ID: 12403225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Post-natal perturbations in the ovary of mice born from mothers treated with estrogens during pregnancy].
    Jean C
    C R Seances Soc Biol Fil; 1967; 161(7):1549-54. PubMed ID: 4231626
    [No Abstract]   [Full Text] [Related]  

  • 12. [Female pseudohermaphroditism of therapeutic origin. Apropos of a case].
    Loewe-Lyon S; Salat J
    Gynecol Obstet (Paris); 1970; 69(2):161-86. PubMed ID: 5446033
    [No Abstract]   [Full Text] [Related]  

  • 13. Classification of intersexuality.
    Boczkowski K
    Pol Med Sci Hist Bull; 1969 Oct; 12(4):173-5. PubMed ID: 5406894
    [No Abstract]   [Full Text] [Related]  

  • 14. External genitalia formation: role of fibroblast growth factor, retinoic acid signaling, and distal urethral epithelium.
    Ogino Y; Suzuki K; Haraguchi R; Satoh Y; Dolle P; Yamada G
    Ann N Y Acad Sci; 2001 Dec; 948():13-31. PubMed ID: 11795391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genital malformations in adult mice resulting from prenatal estrogenic action. II. The female].
    Jean C
    Arch Anat Microsc Morphol Exp; 1968; 57(3):191-226. PubMed ID: 5753098
    [No Abstract]   [Full Text] [Related]  

  • 16. Ontogeny of androgen receptor and disruption of its mRNA expression by exogenous estrogens during morphogenesis of the genital tubercle.
    Agras K; Willingham E; Liu B; Baskin LS
    J Urol; 2006 Oct; 176(4 Pt 2):1883-8. PubMed ID: 16945680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Can the anti-androgenic effect of spironolactone contraindicate its use in pregnancy?].
    Molinatti GM
    Minerva Ginecol; 1980 Apr; 32(4):239-40. PubMed ID: 7383427
    [No Abstract]   [Full Text] [Related]  

  • 18. Male reproductive health and environmental oestrogens.
    Lancet; 1995 Apr; 345(8955):933-5. PubMed ID: 7715286
    [No Abstract]   [Full Text] [Related]  

  • 19. [Can the anti-androgenic effect of spironolactone contraindicate its use in pregnancy?].
    Molinatti GM
    Minerva Med; 1980 Oct; 71(39):2801-2. PubMed ID: 7432689
    [No Abstract]   [Full Text] [Related]  

  • 20. [Surgical diseases and abnormalities in the inguinal area and the external genitalia].
    Stauffer UG
    Ther Umsch; 1983 May; 40(5):437-48. PubMed ID: 6135259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.